mitoxantrone sandoz
sandoz s.p.a. - mitoxantrone - mitoxantrone
mitoxantrone accord
accord healthcare, s.l.u. - mitoxantrone - mitoxantrone
mitoxantrone
crinos s.p.a. - mitoxantrone - mitoxantrone
mitoxantrone bioprogress
bioprogress s.p.a. - mitoxantrone - mitoxantrone
mitoxantrone salus
salus researches s.p.a. - mitoxantrone - mitoxantrone
mitoxantrone mylan
mylan s.p.a. - mitoxantrone - mitoxantrone
mitoxantrone crin ev 20mg 10ml
crinos spa - mitoxantrone cloridrato - preparazione iniettabile - "20 mg/10 ml soluzione iniettabile uso endovenoso" 1 flaconcino 10 ml
novantrone
meda pharma s.p.a. - mitoxantrone - mitoxantrone
onkotrone
baxter s.p.a. - mitoxantrone - mitoxantrone
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - carcinoma, polmone non a piccole cellule - agenti antineoplastici - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.